1802787-87-6

Basic information

• Product Name: N'-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide
• Synonyms: N'-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide
• CAS NO: 1802787-87-6
• Molecular Formula: C29H22N6OS
• Molecular Weight: 502.58958
• Mol File: 1802787-87-6.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N'-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: N'-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide(1802787-87-6)
• EPA Substance Registry System: N'-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide(1802787-87-6)

Safety Data

• Hazardous Substances Data: 1802787-87-6(Hazardous Substances Data)

Upstream product

• 24086-28-0 methyl 3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxylate 
• 947-95-5 5-chloro-4-formyl-3-methyl-1-phenyl-1H-pyrazole 
• 326916-95-4 3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide 
• 21487-45-6 1,3-diphenyl-4-formylpyrazole 

Relevant articles and documents

Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents

In search of new therapeutics with greater potency, three new series of 3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbohydrazide derivatives have been synthesized and evaluated for their in vitro antioxidant and anti-inflammatory activities. The hydrazones bearing a core pyrazole, chromone and tetrazolo[1,5-a]quinoline scaffold showed promising activities. Interestingly, compounds 3a (EC50 = 06.00 ± 2.36) and 5c (EC50 = 07.21 ± 0.67) showed the most potent antioxidant activity, while compounds 3a (EC50 = 10.25 ± 1.08), 7b (EC50 = 10.50 ± 0.99) and 7c (EC50 = 11.18 ± 0.15) showed significant anti-inflammatory activity. Furthermore, molecular docking studies also revealed a significant correlation between the binding score and biological activity for these compounds to describe the molecular basis for the structure activity relationship (SAR) results. As these compounds are good cyclooxygenase inhibitors, isoenzyme inhibitory potency studies are warranted.